CLINICAL_TRIALS ClinicalTrials.gov record with results posted

An Open Label, 4-Week, Phase 2, Maximal Usage Pharmacokinetics and Safety Study of ARQ-151 Cream 0.3% Administered QD in Pediatric Subjects (Ages 2 to 5 Years Old) With Plaque Psoriasis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04746911
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-08-08T00:06:17.316177+00:00
Published At: 2026-08-07T00:00:00+00:00
Record Updated At: 2026-08-07
Results Posted At: 2026-08-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Psoriasis", "Plaque Psoriasis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-08-07"
protocolSection.identificationModule.nctId: "NCT04746911"
protocolSection.identificationModule.officialTitle: "An Open Label, 4-Week, Phase 2, Maximal Usage Pharmacokinetics and Safety Study of ARQ-151 Cream 0.3% Administered QD in Pediatric Subjects (Ages 2 to 5 Years Old) With Plaque Psoriasis"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-08-07"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.